Global Information
회사소개 | 문의 | 비교리스트

항생물질 시장 예측(-2027년) : COVID-19(신종 코로나바이러스 감염증)의 영향과 세계 시장 분석

Antibiotics Market Forecast to 2027 - COVID-19 Impact and Global Analysis by Drug Class; Action Mechanism, and Geography

리서치사 The Insight Partners
발행일 2020년 04월 상품 코드 935346
페이지 정보 영문 156 Pages
가격
US $ 4,550 ₩ 5,451,000 PDF by E-mail (Single User License)
US $ 6,550 ₩ 7,848,000 PDF by E-mail (Site License)
US $ 8,550 ₩ 10,244,000 PDF by E-mail (Enterprise License)


항생물질 시장 예측(-2027년) : COVID-19(신종 코로나바이러스 감염증)의 영향과 세계 시장 분석 Antibiotics Market Forecast to 2027 - COVID-19 Impact and Global Analysis by Drug Class; Action Mechanism, and Geography
발행일 : 2020년 04월 페이지 정보 : 영문 156 Pages

세계의 항생물질 시장은 2019년 433억 4,838만 달러에서 2027년까지 563억 5,133만 달러에 달할 것으로 예상됩니다. 시장은 2020-2027년간 CAGR 3.6%로 성장할 것으로 예측됩니다. 세균 감염 유병률 증가가 항생물질 수요를 세계적으로 증가시키는 주요 요인 중 하나입니다. 그러나 항생물질 개발의 고가 프로세스가 시장 성장에 마이너스 영향을 미칠 가능성이 높아 예측기간 중 시장 성장을 억제합니다. 세균은 미시적이고 단일세포의 편재하는 생물입니다. 세균 감염이란 인체상 또는 체내 유해한 세균주의 증식을 가리킵니다. 이러한 미생물은 신체의 모든 영역으로 감염될 가능성이 있어 심각한 결과로 연결될 수 있습니다. 세균 감염 징조에는 폐렴, 수막염, 식중독 등이 있습니다. 일반적으로 발생하는 몇 개 소아 세균 감염증은 급성 중이염(AOM), 부비강염, 기관지염, 상기도 감염증, 인두염입니다.

세계의 항생물질(Antibiotics) 시장에 대해 조사 분석했으며, 시장 개요, 시장 규모와 예측, 부문별 시장 분석, 지역별 시장 분석, 경쟁 상황 등에 대한 체계적인 정보를 제공합니다.

목차

제1장 서론

제2장 항생물질 시장 : 요점

제3장 조사 방법

제4장 세계의 항생물질 시장 : 시장 상황

  • PEST 분석

제5장 항생물질 시장 : 주요 시장 역학

  • 시장 성장 촉진요인
  • 시장 성장 억제요인
  • 시장 기회
  • 향후 동향
  • 영향 분석

제6장 항생물질 시장 : 세계 시장 분석

  • 세계의 항생물질 시장 매출 예측과 분석
  • 세계의 항생물질 시장 : 지역별 - 예측과 분석
  • 주요 기업의 시장 포지셔닝

제7장 항생물질 시장 분석 : 약제 분류별

  • 개요
  • 약제 분류별
  • 술폰아미드
  • 아미노글리코사이드
  • 카바페넴
  • 마크롤라이드
  • 플루오로퀴놀론
  • 페니실린
  • 세파로스포린
  • 기타

제8장 항생물질 시장 : 작용기서별

  • 개요
  • 작용기서별
  • 미콜산 억제제
  • RNA 합성 억제제
  • DNA 합성 억제제
  • 단백질 합성 억제제
  • 세포벽 합성 억제제
  • 기타

제9장 항생물질 시장 : 지역별 분석

  • 북미 : 항생물질 시장
  • 유럽 : 항생물질 시장
  • 아시아태평양 : 항생물질 시장
  • 중동 및 아프리카 : 항생물질 시장
  • 중남미 : 항생물질 시장

제10장 세계의 항생물질 시장에 대한 COVID-19 팬데믹의 영향

  • 북미 : COVID-19 팬데믹의 영향 평가
  • 유럽 : COVID-19 팬데믹의 영향 평가
  • 아시아태평양 : COVID-19 팬데믹의 영향 평가
  • 기타 지역 : COVID-19 팬데믹의 영향 평가

제11장 항생물질 시장 : 업계 상황

제12장 기업 개요

제13장 부록

KSM 20.05.29

LIST OF TABLES

  • Table 1. North America Antibiotics Market, by Drug Class - Revenue and Forecast to 2027 (USD Million)
  • Table 2. North America Antibiotics Market, by Action Mechanism - Revenue and Forecast to 2027 (USD Million)
  • Table 3. US Antibiotics Market, by Drug Class - Revenue and Forecast to 2027 (USD Million)
  • Table 4. US Antibiotics Market, by Action Mechanism - Revenue and Forecast to 2027 (USD Million)
  • Table 5. Canada Antibiotics Market, by Drug Class - Revenue and Forecast to 2027 (USD Million)
  • Table 6. Canada Antibiotics Market, by Action Mechanism - Revenue and Forecast to 2027 (USD Million)
  • Table 7. Mexico Antibiotics Market, by Drug Class - Revenue and Forecast to 2027 (USD Million)
  • Table 8. Mexico Antibiotics Market, by Action Mechanism - Revenue and Forecast to 2027 (USD Million)
  • Table 9. Europe Antibiotics Market, by Drug Class - Revenue and Forecast to 2027 (USD Million)
  • Table 10. Europe Antibiotics Market, by Action Mechanism - Revenue and Forecast to 2027 (USD Million)
  • Table 11. Germany Antibiotics Market, by Drug Class - Revenue and Forecast to 2027 (USD Million)
  • Table 12. Germany Antibiotics Market, by Action Mechanism - Revenue and Forecast to 2027 (USD Million)
  • Table 13. UK Antibiotics Market, by Drug Class - Revenue and Forecast to 2027 (USD Million)
  • Table 14. UK Antibiotics Market, by Action Mechanism - Revenue and Forecast to 2027 (USD Million)
  • Table 15. France Antibiotics Market, by Drug Class - Revenue and Forecast to 2027 (USD Million)
  • Table 16. France Antibiotics Market, by Action Mechanism - Revenue and Forecast to 2027 (USD Million)
  • Table 17. Spain Antibiotics Market, by Drug Class - Revenue and Forecast to 2027 (USD Million)
  • Table 18. Spain Antibiotics Market, by Action Mechanism - Revenue and Forecast to 2027 (USD Million)
  • Table 19. Italy Antibiotics Market, by Drug Class - Revenue and Forecast to 2027 (USD Million)
  • Table 20. Italy Antibiotics Market, by Action Mechanism - Revenue and Forecast to 2027 (USD Million)
  • Table 21. Asia Pacific Antibiotics Market, by Drug Class - Revenue and Forecast to 2027 (USD Million)
  • Table 22. Asia Pacific Antibiotics Market, by Action Mechanism - Revenue and Forecast to 2027 (USD Million)
  • Table 23. China Antibiotics Market, by Drug Class - Revenue and Forecast to 2027 (USD Million)
  • Table 24. China Antibiotics Market, by Action Mechanism - Revenue and Forecast to 2027 (USD Million)
  • Table 25. Japan Antibiotics Market, by Drug Class - Revenue and Forecast to 2027 (USD Million)
  • Table 26. Japan Antibiotics Market, by Action Mechanism - Revenue and Forecast to 2027 (USD Million)
  • Table 27. India Antibiotics Market, by Drug Class - Revenue and Forecast to 2027 (USD Million)
  • Table 28. India Antibiotics Market, by Action Mechanism - Revenue and Forecast to 2027 (USD Million)
  • Table 29. South Korea Antibiotics Market, by Drug Class - Revenue and Forecast to 2027 (USD Million)
  • Table 30. South Korea Antibiotics Market, by Action Mechanism - Revenue and Forecast to 2027 (USD Million)
  • Table 31. Australia Antibiotics Market, by Drug Class - Revenue and Forecast to 2027 (USD Million)
  • Table 32. Australia Antibiotics Market, by Action Mechanism - Revenue and Forecast to 2027 (USD Million)
  • Table 33. Middle East & Africa Antibiotics Market, by Drug Class - Revenue and Forecast to 2027 (USD Million)
  • Table 34. Middle East & Africa Antibiotics Market, by Action Mechanism - Revenue and Forecast to 2027 (USD Million)
  • Table 35. Saudi Arabia Antibiotics Market, by Drug Class - Revenue and Forecast to 2027 (USD Million)
  • Table 36. Saudi Arabia Antibiotics Market, by Action Mechanism - Revenue and Forecast to 2027 (USD Million)
  • Table 37. UAE Antibiotics Market, by Drug Class - Revenue and Forecast to 2027 (USD Million)
  • Table 38. UAE Antibiotics Market, by Action Mechanism - Revenue and Forecast to 2027 (USD Million)
  • Table 39. South Africa Antibiotics Market, by Drug Class - Revenue and Forecast to 2027 (USD Million)
  • Table 40. South Africa Antibiotics Market, by Action Mechanism - Revenue and Forecast to 2027 (USD Million)
  • Table 41. South and Central America Antibiotics Market, by Drug Class - Revenue and Forecast to 2027 (USD Million)
  • Table 42. South and Central America Antibiotics Market, by Action Mechanism - Revenue and Forecast to 2027 (USD Million)
  • Table 43. Brazil Antibiotics Market, by Drug Class - Revenue and Forecast to 2027 (USD Million)
  • Table 44. Brazil Antibiotics Market, by Action Mechanism - Revenue and Forecast to 2027 (USD Million)
  • Table 45. Argentina Antibiotics Market, by Drug Class - Revenue and Forecast to 2027 (USD Million)
  • Table 46. Argentina Antibiotics Market, by Action Mechanism - Revenue and Forecast to 2027 (USD Million)
  • Table 47. Recent Inorganic Growth Strategies in the antibiotics Market
  • Table 48. Recent Organic Growth Strategies In The Antibiotics Market
  • Table 49. Glossary of Terms, Antibiotics Market

LIST OF FIGURES

  • Figure 1. Antibiotics Market Segmentation
  • Figure 2. Antibiotics Segmentation, By Region
  • Figure 3. Global Antibiotics Market Overview
  • Figure 4. The Cephalosporin Segment Held Largest Share Of Drug Class Segment In Antibiotics Market
  • Figure 5. Asia-Pacific Region Is Expected to Show Remarkable Growth During the Forecast Period
  • Figure 6. Global Antibiotics Market, By Geography (US$ Million)
  • Figure 7. Global Antibiotics Market- Leading Country Markets (US$ Million)
  • Figure 8. Global Antibiotics Market, Industry Landscape
  • Figure 9. North America PEST Analysis
  • Figure 10. Europe PEST Analysis
  • Figure 11. Asia Pacific PEST Analysis
  • Figure 12. Middle East & Africa PEST Analysis
  • Figure 13. South & Central America PEST Analysis
  • Figure 14. Antibiotics market impact analysis of driver and restraints
  • Figure 15. Global Antibiotics Market - Revenue Forecast And Analysis - 2019- 2027
  • Figure 16. Global Antibiotics Market - By Geography Forecast And Analysis - 2019- 2027
  • Figure 17. Market Positioning Of Key Players In Global Antibiotics Market
  • Figure 18. Antibiotics Market Revenue Share, by Drug Class (2019 and 2027)
  • Figure 19. Sulfonamides: Antibiotics Market - Revenue and Forecast to 2027 (US$ Million)
  • Figure 20. Aminoglycosides: Antibiotics Market - Revenue and Forecast to 2027 (US$ Million)
  • Figure 21. Carbapenem: Antibiotics Market - Revenue and Forecast to 2027 (US$ Million)
  • Figure 22. Macrolides: Antibiotics Market - Revenue and Forecast to 2027 (US$ Million)
  • Figure 23. Fluoroquinolones: Antibiotics Market - Revenue and Forecast to 2027 (US$ Million)
  • Figure 24. Penicillin: Antibiotics Market - Revenue and Forecast to 2027 (US$ Million)
  • Figure 25. Cephalosporin: Antibiotics Market - Revenue and Forecast to 2027 (US$ Million)
  • Figure 26. Others: Antibiotics Market - Revenue and Forecast to 2027 (US$ Million)
  • Figure 27. Antibiotics Market, by Action Mechanism, 2019 and 2027 (%)
  • Figure 28. Mycolic Acid Inhibitors: Antibiotics Market - Revenue and Forecast to 2027 (US$ Million)
  • Figure 29. RNA Synthesis Inhibitors: Antibiotics Market - Revenue and Forecast to 2027 (US$ Million)
  • Figure 30. DNA Synthesis Inhibitors: Antibiotics Market - Revenue and Forecast to 2027 (US$ Million)
  • Figure 31. Protein Synthesis Inhibitors: Antibiotics Market - Revenue and Forecast to 2027 (US$ Million)
  • Figure 32. Cell Wall Synthesis Inhibitors: Antibiotics Market - Revenue and Forecast to 2027 (US$ Million)
  • Figure 33. Others: Antibiotics Market - Revenue and Forecast to 2027 (US$ Million)
  • Figure 34. North America: Antibiotics Market, by Key Country - Revenue (2019) (USD Million)
  • Figure 35. North America Antibiotics Market Revenue and Forecast to 2027 (USD Million)
  • Figure 36. North America: Antibiotics Market, by Country, 2019 & 2027 (%)
  • Figure 37. US: Antibiotics Market - Revenue and Forecast to 2027 (USD Million)
  • Figure 38. Canada: Antibiotics Market - Revenue and Forecast to 2027 (USD Million)
  • Figure 39. Mexico: Antibiotics Market - Revenue and Forecast to 2027 (USD Million)
  • Figure 40. Europe: Antibiotics Market, by Key Country - Revenue (2019) (USD Million)
  • Figure 41. Europe Antibiotics Market Revenue and Forecast to 2027 (USD Million)
  • Figure 42. Europe: Antibiotics Market, by Country, 2018 & 2027 (%)
  • Figure 43. Germany: Antibiotics Market - Revenue and Forecast to 2027 (USD Million)
  • Figure 44. UK: Antibiotics Market - Revenue and Forecast to 2027 (USD Million)
  • Figure 45. France: Antibiotics Market - Revenue and Forecast to 2027 (USD Million)
  • Figure 46. Spain: Antibiotics Market - Revenue and Forecast to 2027 (USD Million)
  • Figure 47. Italy: Antibiotics Market - Revenue and Forecast to 2027 (USD Million)
  • Figure 48. Asia Pacific: Antibiotics Market, by Key Country - Revenue (2019) (USD Million)
  • Figure 49. Asia Pacific Antibiotics Market Revenue and Forecast to 2027 (USD Million)
  • Figure 50. China: Antibiotics Market - Revenue and Forecast to 2027 (USD Million)
  • Figure 51. Japan: Antibiotics Market - Revenue and Forecast to 2027 (USD Million)
  • Figure 52. India: Antibiotics Market - Revenue and Forecast to 2027 (USD Million)
  • Figure 53. South Korea: Antibiotics Market - Revenue and Forecast to 2027 (USD Million)
  • Figure 54. Australia: Antibiotics Market - Revenue and Forecast to 2027 (USD Million)
  • Figure 55. Middle East & Africa: Antibiotics Market, by Key Country - Revenue (2019) (USD Million)
  • Figure 56. Middle East & Africa Antibiotics Market Revenue and Forecast to 2027 (USD Million)
  • Figure 57. Middle East & Africa: Antibiotics Market Share by Country - 2019 & 2027, (%)
  • Figure 58. Saudi Arabia: Antibiotics Market - Revenue and Forecast to 2027 (USD Million)
  • Figure 59. UAE: Antibiotics Market - Revenue and Forecast to 2027 (US$ Million)
  • Figure 60. South Africa: Antibiotics Market - Revenue and Forecast to 2027 (USD Million)
  • Figure 61. South and Central America: Antibiotics Market, by Key Country - Revenue (2019) (USD Million)
  • Figure 62. South and Central America Antibiotics Market Revenue and Forecast to 2027 (USD Million)
  • Figure 63. South and Central America: Antibiotics Market, by Country, 2019 & 2027 (%)
  • Figure 64. Brazil: Antibiotics Market - Revenue and Forecast to 2027 (USD Million)
  • Figure 65. Argentina: Antibiotics Market - Revenue and Forecast to 2027 (USD Million)
  • Figure 66. Impact Of Covid-19 Pandemic In North American Country Markets
  • Figure 67. Impact Of Covid-19 Pandemic In Europe Country Markets
  • Figure 68. Impact Of Covid-19 Pandemic In Asia-Pacific Country Markets
  • Figure 69. Impact Of Covid-19 Pandemic In Rest Of World Country Markets
  • Figure 70. Growth Strategies in The Antibiotics Market, 2016-2020

The antibiotics was valued at US$ 43,348.38 million in 2019 and is projected to reach US$ 56,351.33 million by 2027; it is expected to grow at a CAGR of 3.6% from 2020 to 2027.

The growing prevalence of bacterial infection is one of the major factors increasing the demand for antibiotics globally. However, expensive process of antibiotic development is likely to pose a negative impact on the market growth, which in turn will restrain the growth of the market during the forecast years.

Bacteria are microscopic and single-cell omnipresent organisms. Bacterial infection refers to the proliferation of harmful bacterial strains on or inside the human body. These microorganisms can infect any area of the body and may lead to severe consequences. A few of the indications of bacterial infections include pneumonia, meningitis, and food poisoning. Several commonly occurring pediatric bacterial infections are acute otitis media (AOM), sinusitis, bronchitis, upper respiratory tract infection, and pharyngitis.

The prevalence of infectious disease caused by bacteria is increasing day by day worldwide. According to a study published by the American Society for Microbiology (ASM) in 2019, 1.5-4.5 million infections across the world are caused by the Carbapenem-resistant bacterial strains belonging to the Enterobacteriaceae group every year. Additionally, the same risk factor leads to ~49,000 hospitalization cases in the US every year. Moreover, according to a study published by UNICEF, in 2018, pneumonia was the cause for ~1,755,000 deaths among children below the age of five; moreover, ~1,200,000 children lost their lives by diarrhea around the globe. Further, according to a study published by the NCBI in 2018, campylobacterial infection, which is transmitted through the consumption of poultry, is one of the leading causes of bacterial foodborne infections in developed countries, which is causing a major economic burden. According to estimates given by the World Health Organization (WHO) in 2018, every year, ~33 million people die of campylobacteriosis worldwide. Such potential increase in prevalence of bacterial infections is expected to continue to drive the growth of antibiotics market during the forecast period. Thus, the increasing prevalence of such drug-resistant bacteria compels the manufacturers and R&D faculties to come up with new variants of antimicrobials effective against the new, as well as old, bacterial strains, thereby fueling the growth of the antibiotics market.

The global antibiotics market is segmented into drug class and action mechanism. Based on drug class, the antibiotics market is segmented into sulfonamides, aminoglycosides, carbapenem, macrolides, fluoroquinolones, penicillin, cephalosporin, and others. The cephalosporin segment held the largest share of the market in 2019; whereas the fluoroquinolones segment is anticipated to register the highest CAGR in the market during the forecast period. Based on action mechanism, the antibiotics market is segmented into mycolic acid inhibitors, RNA synthesis inhibitors, DNA synthesis inhibitors, protein synthesis inhibitors, and cell wall synthesis inhibitors. The cell wall synthesis inhibitors segment held the largest share of the market in 2019; whereas the DNA synthesis inhibitors segment is estimated to register the highest CAGR in the market during the forecast period.

A few of the essential primary and secondary sources referred during the preparation of the report are, Food and Drug Administration, World Health Organization (WHO), Organization for Economic Co-operation and Development, and National Cancer Foundations

Reasons to Buy

Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the antibiotics market.

Highlights key business priorities in order to assist companies to realign their business strategies.

The key findings and recommendations highlight crucial progressive industry trends in the global antibiotics market, thereby allowing players across the value chain to develop effective long-term strategies.

Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.

Scrutinize in-depth global market trends and outlook coupled with the factors driving the market, as well as those hindering it.

Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution.

TABLE OF CONTENTS

1. Introduction

  • 1.1 Scope of the Study
  • 1.2 The Insight Partners Research Report Guidance
  • 1.3 Market Segmentation
    • 1.3.1 Global Antibiotics Market - By Drug Class
    • 1.3.2 Global Antibiotics Market - By Action Mechanism
    • 1.3.3 Global Antibiotics Market - By Geography

2. Antibiotics Market - Key Takeaways

3. Research Methodology

  • 3.1 Coverage
  • 3.2 Secondary Research
  • 3.3 Primary Research

4. Global Antibiotics Market - Market Landscape

  • 4.1 Pest Analysis
    • 4.1.1 North America- PEST Analysis
    • 4.1.2 Europe- PEST Analysis
    • 4.1.3 Asia Pacific
    • 4.1.4 Middle East & Africa
    • 4.1.5 South & Central America

5. Antibiotics Market - Key Market Dynamics

  • 5.1 Market Drivers
    • 5.1.1 Rising Prevalence of Bacterial Infections
    • 5.1.2 Increasing Development of Generic Drugs
  • 5.2 Market Restraints
    • 5.2.1 Tedious and Expensive Process of Antibiotic Development
  • 5.3 Market Opportunities
    • 5.3.1 Growing Investments to Combat Antimicrobial Resistance
  • 5.4 Future Trends
    • 5.4.1 Incorporation of Novel Computing Technologies for Antibiotics Discovery
  • 5.5 Impact analysis

6. Antibiotics Market - Global Analysis

  • 6.1 Global Antibiotics Market Revenue Forecast And Analysis
  • 6.2 Global Antibiotics Market, By Geography - Forecast And Analysis
  • 6.3 Market Positioning of Key Players

7. Antibiotics Market Analysis - By Drug Class

  • 7.1 Overview
  • 7.2 Antibiotics Market Revenue Share, by Drug Class (2019 and 2027)
  • 7.3 Sulfonamides
    • 7.3.1 Overview
    • 7.3.2 Sulfonamides: Antibiotics Market - Revenue and Forecast to 2027 (US$ Million)
  • 7.4 Aminoglycosides
    • 7.4.1 Overview
    • 7.4.2 Aminoglycosides: Antibiotics Market - Revenue and Forecast to 2027 (US$ Million)
  • 7.5 Carbapenem
    • 7.5.1 Overview
    • 7.5.2 Carbapenem: Antibiotics Market - Revenue and Forecast to 2027 (US$ Million)
  • 7.6 Macrolides
    • 7.6.1 Overview
    • 7.6.2 Macrolides: Antibiotics Market - Revenue and Forecast to 2027 (US$ Million)
  • 7.7 Fluoroquinolones
    • 7.7.1 Overview
    • 7.7.2 Fluoroquinolones: Antibiotics Market - Revenue and Forecast to 2027 (US$ Million)
  • 7.8 Penicillin
    • 7.8.1 Overview
    • 7.8.2 Penicillin: Antibiotics Market - Revenue and Forecast to 2027 (US$ Million)
  • 7.9 Cephalosporin
    • 7.9.1 Overview
    • 7.9.2 Cephalosporin: Antibiotics Market - Revenue and Forecast to 2027 (US$ Million)
  • 7.10 Others
    • 7.10.1 Overview
    • 7.10.2 Others: Antibiotics Market - Revenue and Forecast to 2027 (US$ Million)

8. Antibiotics Market - By Action Mechanism

  • 8.1 Overview
  • 8.2 Antibiotics Market, by Action Mechanism, 2019 and 2027 (%)
  • 8.3 Mycolic Acid Inhibitors
    • 8.3.1 Overview
    • 8.3.2 Mycolic Acid Inhibitors: Antibiotics Market - Revenue and Forecast to 2027 (US$ Million)
  • 8.4 RNA Synthesis Inhibitors
    • 8.4.1 Overview
    • 8.4.2 RNA Synthesis Inhibitors: Antibiotics Market - Revenue and Forecast to 2027 (US$ Million)
  • 8.5 DNA Synthesis Inhibitors
    • 8.5.1 Overview
    • 8.5.2 DNA Synthesis Inhibitors: Antibiotics Market - Revenue and Forecast to 2027 (US$ Million)
  • 8.6 Protein Synthesis Inhibitors
    • 8.6.1 Overview
    • 8.6.2 Protein Synthesis Inhibitors: Antibiotics Market - Revenue and Forecast to 2027 (US$ Million)
  • 8.7 Cell Wall Synthesis Inhibitors
    • 8.7.1 Overview
    • 8.7.2 Cell Wall Synthesis Inhibitors: Antibiotics Market - Revenue and Forecast to 2027 (US$ Million)
  • 8.8 Others
    • 8.8.1 Overview
    • 8.8.2 Others: Antibiotics Market - Revenue and Forecast to 2027 (US$ Million)

9. Antibiotics Market - Geographic Analysis

  • 9.1 North America: Antibiotics Market
    • 9.1.1 Overview
    • 9.1.2 North America: Antibiotics Market - Revenue and Forecast to 2027 (USD Million)
    • 9.1.3 North America: Antibiotics Market, by Drug Class, 2018-2027 (USD Million)
    • 9.1.4 North America: Antibiotics Market, by Action Mechanism, 2018-2027 (USD Million)
    • 9.1.5 North America: Antibiotics Market, by Country, 2019 & 2027 (%)
    • 9.1.6 US: Antibiotics Market - Revenue and Forecast to 2027 (USD Million)
      • 9.1.6.1 US: Antibiotics Market - Revenue and Forecast to 2027 (USD Million)
      • 9.1.6.2 US: Antibiotics Market, by Drug Class, 2018-2027 (USD Million)
      • 9.1.6.3 US: Antibiotics Market, by Action Mechanism, 2018-2027 (USD Million)
    • 9.1.7 Canada: Antibiotics Market - Revenue and Forecast to 2027 (USD Million)
      • 9.1.7.1 Canada: Antibiotics Market - Revenue and Forecast to 2027 (USD Million)
      • 9.1.7.2 Canada: Antibiotics Market, by Drug Class, 2018-2027 (USD Million)
      • 9.1.7.3 Canada: Antibiotics Market, by Action Mechanism, 2018-2027 (USD Million)
    • 9.1.8 Mexico: Antibiotics Market - Revenue and Forecast to 2027 (USD Million)
      • 9.1.8.1 Mexico: Antibiotics Market - Revenue and Forecast to 2027 (USD Million)
      • 9.1.8.2 Mexico: Antibiotics Market, by Drug Class, 2018-2027 (USD Million)
      • 9.1.8.3 Mexico: Antibiotics Market, by Action Mechanism, 2018-2027 (USD Million)
  • 9.2 Europe: Antibiotics Market
    • 9.2.1 Overview
    • 9.2.2 Europe: Antibiotics Market - Revenue and Forecast to 2027 (USD Million)
    • 9.2.3 Europe: Antibiotics Market, by Drug Class, 2018-2027 (USD Million)
    • 9.2.4 Europe: Antibiotics Market, by Action Mechanism, 2018-2027 (USD Million)
    • 9.2.5 Europe: Antibiotics Market, by Country, 2018 & 2027 (%)
    • 9.2.6 Germany: Antibiotics Market - Revenue and Forecast to 2027 (USD Million)
      • 9.2.6.1 Germany: Antibiotics Market - Revenue and Forecast to 2027 (USD Million)
      • 9.2.6.2 Germany: Antibiotics Market, by Drug Class, 2018-2027 (USD Million)
      • 9.2.6.3 Germany: Antibiotics Market, by Action Mechanism, 2018-2027 (USD Million)
    • 9.2.7 UK: Antibiotics Market - Revenue and Forecast to 2027 (USD Million)
      • 9.2.7.1 UK: Antibiotics Market - Revenue and Forecast to 2027 (USD Million)
      • 9.2.7.2 UK: Antibiotics Market, by Drug Class, 2018-2027 (USD Million)
      • 9.2.7.3 UK: Antibiotics Market, by Action Mechanism, 2018-2027 (USD Million)
    • 9.2.8 France: Antibiotics Market - Revenue and Forecast to 2027 (USD Million)
      • 9.2.8.1 France: Antibiotics Market - Revenue and Forecast to 2027 (USD Million)
      • 9.2.8.2 France: Antibiotics Market, by Drug Class, 2018-2027 (USD Million)
      • 9.2.8.3 France: Antibiotics Market, by Action Mechanism, 2018-2027 (USD Million)
    • 9.2.9 Spain: Antibiotics Market - Revenue and Forecast to 2027 (USD Million)
      • 9.2.9.1 Spain: Antibiotics Market - Revenue and Forecast to 2027 (USD Million)
      • 9.2.9.2 Spain: Antibiotics Market, by Drug Class, 2018-2027 (USD Million)
      • 9.2.9.3 Spain: Antibiotics Market, by Action Mechanism, 2018-2027 (USD Million)
    • 9.2.10 Italy: Antibiotics Market - Revenue and Forecast to 2027 (USD Million)
      • 9.2.10.1 Italy: Antibiotics Market - Revenue and Forecast to 2027 (USD Million)
      • 9.2.10.2 Italy: Antibiotics Market, by Drug Class, 2018-2027 (USD Million)
      • 9.2.10.3 Italy: Antibiotics Market, by Action Mechanism, 2018-2027 (USD Million)
  • 9.3 Asia Pacific: Antibiotics Market
    • 9.3.1 Overview
    • 9.3.2 Asia Pacific: Antibiotics Market - Revenue and Forecast to 2027 (USD Million)
    • 9.3.3 Asia Pacific: Antibiotics Market, by Drug Class, 2018-2027 (USD Million)
    • 9.3.4 Asia Pacific: Antibiotics Market, by Action Mechanism, 2018-2027 (USD Million)
    • 9.3.5 Asia Pacific: Antibiotics Market, by Country, 2018 & 2027 (%)
    • 9.3.6 China: Antibiotics Market - Revenue and Forecast to 2027 (USD Million)
      • 9.3.6.1 China: Antibiotics Market - Revenue and Forecast to 2027 (USD Million)
      • 9.3.6.2 China: Antibiotics Market, by Drug Class, 2018-2027 (USD Million)
      • 9.3.6.3 China: Antibiotics Market, by Action Mechanism, 2018-2027 (USD Million)
    • 9.3.7 Japan: Antibiotics Market - Revenue and Forecast to 2027 (USD Million)
      • 9.3.7.1 Japan: Antibiotics Market - Revenue and Forecast to 2027 (USD Million)
      • 9.3.7.2 Japan: Antibiotics Market, by Drug Class, 2018-2027 (USD Million)
      • 9.3.7.3 Japan: Antibiotics Market, by Action Mechanism, 2018-2027 (USD Million)
    • 9.3.8 India: Antibiotics Market - Revenue and Forecast to 2027 (USD Million)
      • 9.3.8.1 India: Antibiotics Market - Revenue and Forecast to 2027 (USD Million)
      • 9.3.8.2 India: Antibiotics Market, by Drug Class, 2018-2027 (USD Million)
      • 9.3.8.3 India: Antibiotics Market, by Action Mechanism, 2018-2027 (USD Million)
    • 9.3.9 South Korea: Antibiotics Market - Revenue and Forecast to 2027 (USD Million)
      • 9.3.9.1 South Korea: Antibiotics Market - Revenue and Forecast to 2027 (USD Million)
      • 9.3.9.2 South Korea: Antibiotics Market, by Drug Class, 2018-2027 (USD Million)
      • 9.3.9.3 South Korea: Antibiotics Market, by Action Mechanism, 2018-2027 (USD Million)
    • 9.3.10 Australia: Antibiotics Market - Revenue and Forecast to 2027 (USD Million)
      • 9.3.10.1 Australia: Antibiotics Market - Revenue and Forecast to 2027 (USD Million)
      • 9.3.10.2 Australia: Antibiotics Market, by Drug Class, 2018-2027 (USD Million)
      • 9.3.10.3 Australia: Antibiotics Market, by Action Mechanism, 2018-2027 (USD Million)
  • 9.4 Middle East & Africa: Antibiotics Market
    • 9.4.1 Overview
    • 9.4.2 Middle East & Africa: Antibiotics Market - Revenue and Forecast to 2027 (USD Million)
    • 9.4.3 Middle East & Africa: Antibiotics Market, by Drug Class, 2018-2027 (USD Million)
    • 9.4.4 Middle East & Africa: Antibiotics Market, by Action Mechanism, 2018-2027 (USD Million)
    • 9.4.5 Middle East & Africa: Antibiotics Market Share by Country - 2019 & 2027, (%)
    • 9.4.6 Saudi Arabia: Antibiotics Market - Revenue and Forecast to 2027 (USD Million)
      • 9.4.6.1 Saudi Arabia: Antibiotics Market - Revenue and Forecast to 2027 (USD Million)
      • 9.4.6.2 Saudi Arabia: Antibiotics Market, by Drug Class, 2018-2027 (USD Million)
      • 9.4.6.3 Saudi Arabia: Antibiotics Market, by Action Mechanism, 2018-2027 (USD Million)
    • 9.4.7 UAE: Antibiotics Market - Revenue and Forecast to 2027 (USD Million)
      • 9.4.7.1 UAE: Antibiotics Market - Revenue and Forecast to 2027 (USD Million)
      • 9.4.7.2 UAE: Antibiotics Market, by Drug Class, 2018-2027 (USD Million)
      • 9.4.7.3 UAE: Antibiotics Market, by Action Mechanism, 2018-2027 (USD Million)
    • 9.4.8 South Africa: Antibiotics Market - Revenue and Forecast to 2027 (US$ Million)
      • 9.4.8.1 South Africa: Antibiotics Market - Revenue and Forecast to 2027 (USD Million)
      • 9.4.8.2 South Africa: Antibiotics Market, by Drug Class, 2018-2027 (USD Million)
      • 9.4.8.3 South Africa: Antibiotics Market, by Action Mechanism, 2018-2027 (USD Million)
  • 9.5 South and Central America: Antibiotics Market
    • 9.5.1 Overview
    • 9.5.2 South and Central America: Antibiotics Market - Revenue and Forecast to 2027 (USD Million)
    • 9.5.3 South and Central America: Antibiotics Market, by Drug Class, 2018-2027 (USD Million)
    • 9.5.4 South and Central America: Antibiotics Market, by Action Mechanism, 2018-2027 (USD Million)
    • 9.5.5 South and Central America: Antibiotics Market, by Country, 2019 & 2027 (%)
    • 9.5.6 Brazil: Antibiotics Market - Revenue and Forecast to 2027 (USD Million)
      • 9.5.6.1 Brazil: Antibiotics Market - Revenue and Forecast to 2027 (USD Million)
      • 9.5.6.2 Brazil: Antibiotics Market, by Drug Class, 2018-2027 (USD Million)
      • 9.5.6.3 Brazil: Antibiotics Market, by Action Mechanism, 2018-2027 (USD Million)
    • 9.5.7 Argentina: Antibiotics Market - Revenue and Forecast to 2027 (USD Million)
      • 9.5.7.1 Argentina: Antibiotics Market - Revenue and Forecast to 2027 (USD Million)
      • 9.5.7.2 Argentina: Antibiotics Market, by Drug Class, 2018-2027 (USD Million)
      • 9.5.7.3 Argentina: Antibiotics Market, by Action Mechanism, 2018-2027 (USD Million)

10. IMPACT OF COVID-19 PANDEMIC ON GLOBAL ANTIBIOTICS MARKET

  • 10.1 North America: Impact assessment of COVID-19 Pandemic
  • 10.2 Europe: Impact assessment of COVID-19 Pandemic
  • 10.3 Asia-Pacific: Impact assessment of COVID-19 Pandemic
  • 10.4 Rest of World: Impact assessment of COVID-19 Pandemic

11. Antibiotics Market -Industry Landscape

  • 11.1 Overview
  • 11.2 Growth Strategies in The Antibiotics Market, 2016-2020
  • 11.3 Inorganic Growth Strategies
    • 11.3.1 Overview
  • 11.4 Organic Growth Strategies
    • 11.4.1 Overview

12. COMPANY PROFILES

  • 12.1 GlaxoSmithKline plc.
    • 12.1.1 Key Facts
    • 12.1.2 Business Description
    • 12.1.3 Products and Services
    • 12.1.4 Financial Overview
    • 12.1.5 SWOT Analysis
    • 12.1.6 Key Developments
  • 12.2 Sanofi
    • 12.2.1 Key Facts
    • 12.2.2 Business Description
    • 12.2.3 Products and Services
    • 12.2.4 Financial Overview
    • 12.2.5 SWOT Analysis
    • 12.2.6 Key Developments
  • 12.3 Novartis AG
    • 12.3.1 Key Facts
    • 12.3.2 Business Description
    • 12.3.3 Products and Services
    • 12.3.4 Financial Overview
    • 12.3.5 SWOT Analysis
    • 12.3.6 Key Developments
  • 12.4 Pfizer Inc.
    • 12.4.1 Key Facts
    • 12.4.2 Business Description
    • 12.4.3 Products and Services
    • 12.4.4 Financial Overview
    • 12.4.5 SWOT Analysis
    • 12.4.6 Key Developments
  • 12.5 Bayer AG
    • 12.5.1 Key Facts
    • 12.5.2 Business Description
    • 12.5.3 Products and Services
    • 12.5.4 Financial Overview
    • 12.5.5 SWOT Analysis
    • 12.5.6 Key Developments
  • 12.6 Johnson & Johnson Services, Inc.
    • 12.6.1 Key Facts
    • 12.6.2 Business Description
    • 12.6.3 Products and Services
    • 12.6.4 Financial Overview
    • 12.6.5 SWOT Analysis
    • 12.6.6 Key Developments
  • 12.7 Bristol-Myers Squibb Company
    • 12.7.1 Key Facts
    • 12.7.2 Business Description
    • 12.7.3 Products and Services
    • 12.7.4 Financial Overview
    • 12.7.5 SWOT Analysis
    • 12.7.6 Key Developments
  • 12.8 Astellas Pharma Inc.
    • 12.8.1 Key Facts
    • 12.8.2 Business Description
    • 12.8.3 Products and Services
    • 12.8.4 Financial Overview
    • 12.8.5 SWOT Analysis
    • 12.8.6 Key Developments
  • 12.9 Abbott
    • 12.9.1 Key Facts
    • 12.9.2 Business Description
    • 12.9.3 Products and Services
    • 12.9.4 Financial Overview
    • 12.9.5 SWOT Analysis
    • 12.9.6 Key Developments
  • 12.10 Eli Lilly and Company.
    • 12.10.1 Key Facts
    • 12.10.2 Business Description
    • 12.10.3 Products and Services
    • 12.10.4 Financial Overview
    • 12.10.5 SWOT Analysis
    • 12.10.6 Key Developments

13. Appendix

  • 13.1 About The Insight Partners
  • 13.2 Glossary of Terms
Back to Top
전화 문의
F A Q